Search results for "Perch"

showing 10 items of 1084 documents

CCDC 973767: Experimental Crystal Structure Determination

2014

Related Article: Alexandre Abhervé, Juan Modesto Clemente-Juan, Miguel Clemente-León, Eugenio Coronado, Jaursup Boonmak, Sujittra Youngme|2014|New J.Chem.|38|2105|doi:10.1039/C3NJ01516E

hexakis(mu-NN'-ethane-12-diylbis(1-(5-methyl-1H-imidazol-4-yl)methanimine))-tris(mu-oxo)-hexakis(isothiocyanato)-hexa-iron(iii) diperchlorate tetrakis(thiocyanate) diethyl ether methanol solvate hydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Treatment of primary hypercholesterolemia: comparison of the effectiveness of different statins

2000

hypercholesterolemiastatins LDL-C
researchProduct

Nelipīdu riska faktoru izvērtējums pacientiem ar ģimenes hiperholesterolēmiju

2018

Pamatojums: Ģimenes Hiperholesterinēmija (ĢH) raksturojas ar paaugstinātu zema blīvuma lipoproteīnu holesterīna (ZBL-H) koncentrāciju, kas ievērojami paaugstina agrīnu kardiovaskulāro slimību (KVS) attīstības risku. Papildus (ZBL-H) citu, ar lipīdiem nesaistītu, riska faktoru nozīmīgai ietekmei uz KVS attīstības risku, ir svarīga to identifikācija un kontrole jau dzīves laikā vai kopš bērnības. Mērķis: Raksturot un identificēt biežākos ar lipīdiem nesaistītus riska faktorus, kas var veicināt KVS attīstību pacientiem ar ĢH, kas tādējādi varētu palīdzēt akcentēt nozīmi to turpmākai kontrolei. Materiāli un metodes: Šī ir retrospektīva kohorta analīze pacientu grupai ar ticamu vai drošu ĢH diag…

hypertensioncardiovascular diseaseFamilial HypercholesterolaemiaMedicīnaNon-lipid risk factors
researchProduct

Sorption of uranium(VI) onto ferric oxides in sulfate-rich acid waters.

2003

The mechanisms of the uranium(VI) sorption on schwertmannite and goethite in acid sulfate-rich solutions were studied by Extended X-ray Absorption Fine Structure (EXAFS) spectroscopy. The samples were prepared under N2 atmosphere and initial uranium(VI) concentrations of 1 x 10(-5) (pH 6.5) to 5 x 10(-5) M (pH 4.2). The ionic strength was adjusted using 0.01 M Na2SO4 or 0.01 M NaClO4, respectively. The EXAFS structural parameters for uranium(VI) sorbed on goethite in sulfate-rich, acid and near-neutral solutions indicate that uranium(VI) forms an inner-sphere, mononuclear, bidentate surface complex. This complex is characterized by a uranium-ferric-iron distance of approximately 3.45 A. Ura…

inorganic chemicalsWater Pollutants RadioactiveGoethiteschwertmanniteInorganic chemistrychemistry.chemical_elementcomplex mixturesFerric Compoundsuraniumchemistry.chemical_compoundPerchlorateAdsorptionmedicinegoethiteEnvironmental ChemistrySulfatesorptionSulfatesSchwertmannitetechnology industry and agricultureSorptionGeneral ChemistryUraniumEXAFSchemistryvisual_artvisual_art.visual_art_mediumFerricUraniumAdsorptionacid mine drainagemedicine.drugEnvironmental MonitoringEnvironmental sciencetechnology
researchProduct

Cormorant predation mortality of perch (Perca fluviatilis) in coastal and archipelago areas, northern Baltic Sea

2021

Abstract Perch (Perca fluviatilis) is an important prey species of the great cormorant (Phalacrocorax carbo sinensis) in the coastal waters of the northern Baltic Sea. The annual predation mortality caused by cormorants was estimated based on the consumed numbers of perch in relation to the abundance of perch in vulnerable age groups in the sea. We used existing stock assessment data (Archipelago Sea) or a simple population model in other areas (Gulf of Finland, Bothnian Sea, and Quark), based on commercial and recreational perch catches, and estimated fishing and natural mortalities, with distributions describing our understanding about the likelihood of different values for every variable…

kuolleisuusBaltic SeaAquatic ScienceOceanographycormorantperchrannikotahvenvieraslajitEcology Evolution Behavior and SystematicskalatPhalacrocorax carbo sinensisEcologykalakannatmortalityekologiaPerca fluviatilissaalistuscoastal fisheriesmerimetsoItämerieläinekologialinnutpredationrannikkovedetmerimetso (laji)
researchProduct

Complex dynamics, hidden attractors and continuous approximation of a fractional-order hyperchaotic PWC system

2018

In this paper, a continuous approximation to studying a class of PWC systems of fractionalorder is presented. Some known results of set-valued analysis and differential inclusions are utilized. The example of a hyperchaotic PWC system of fractional order is analyzed. It is found that without equilibria, the system has hidden attractors.

likiarvotFOS: Physical sciencesAerospace EngineeringattraktoritOcean EngineeringDynamical Systems (math.DS)hidden chaotic attractor01 natural sciences010305 fluids & plasmasDifferential inclusion0103 physical sciencesAttractorFOS: MathematicsApplied mathematicsOrder (group theory)Mathematics - Dynamical Systemsdynaamiset systeemitElectrical and Electronic Engineering010301 acousticsMathematicskaaosteoriaContinuous approximationmurtoluvutperiodicity of fractional-order systemPWC system of fractional orderApplied MathematicsMechanical EngineeringNonlinear Sciences - Chaotic DynamicsNonlinear Sciences::Chaotic DynamicsComplex dynamicshyperchaosControl and Systems Engineeringcontinuous approximationapproksimointiChaotic Dynamics (nlin.CD)Nonlinear Dynamics
researchProduct

The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes ?

2009

Ezetimibe represents the first of a new class of agents, the cholesterol absorption inhibitors, able to reduce low-density lipoproteins (LDL)-cholesterol by 15-25% from baseline in monotherapy and on top of statins and fibrates. To-date all the data regarding the efficacy of ezetimibe comes from the studies of its lipid-lowering power. Yet, recent findings from the ENHANCE study on atherosclerosis progression showed that the addition of ezetimibe to simvastatin in patients with heterozygous familial hypercholesterolemia did not affect the mean change in carotid intima-media thickness, although a significant reduction in LDL-cholesterol levels was present. Therefore, we cannot exclude that e…

medicine.medical_specialty10265 Clinic for Endocrinology and Diabetology610 Medicine & healthFamilial hypercholesterolemiaBioinformatics2705 Cardiology and Cardiovascular Medicinechemistry.chemical_compoundEzetimibePredictive Value of TestsInternal medicinemedicineAnimalsHumansProspective cohort studyCardiovascular risk Cholesterol LDL size Small dense LDLDyslipidemiasEzetimibe LDL-cholesterolCholesterolVascular diseasebusiness.industryAnticholesteremic AgentsHypertriglyceridemiaReproducibility of ResultsCholesterol LDLEzetimibemedicine.diseaseTreatment OutcomeEndocrinologychemistrySimvastatinAzetidinesDrug Therapy Combinationlipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessBiomarkersDyslipidemiamedicine.drug
researchProduct

Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children.

2018

Dyslipdiemia can manifest at a young age, and it is a risk factor for atherosclerotic cardiovascular disease (ASCVD), the principal cause of mortality in developed nations. Therefore, treating it a...

medicine.medical_specialtyAdolescentFamilial hypercholesterolemiastatins03 medical and health sciences0302 clinical medicineEzetimibechildrenmedicinePharmacology (medical)Risk factorIntensive care medicinePharmacologyfamilial hypercholesterolemiaAtherosclerotic cardiovascular diseasebusiness.industryfungidyslipidemiafood and beveragesGeneral Medicinemedicine.diseaseYoung age030220 oncology & carcinogenesisbusinessDeveloped country030217 neurology & neurosurgeryDyslipidemiamedicine.drugezetimibeExpert opinion on pharmacotherapy
researchProduct

Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance ?

2009

Summary Background:  Statins have emerged as the global leader in pharmacologic therapy for dyslipidaemia, and rosuvastatin has demonstrated clinical efficacy as well as safety in several clinical trials and postmarketing analyses. Aim:  The present article reviewed the effects of rosuvastatin on the quantity and the quality of low-density lipoproteins (LDL). Methods:  We searched for and reviewed all the available evidence in a systematic way. A literature search (by Medline and Scopus) was performed using the following headings: ‘LDL-cholesterol’, ‘LDL size’, ‘LDL subclasses’, ‘small dense LDL’, ‘apolipoprotein B, apo B’ and ‘rosuvastatin’ up to 11 November 2008. The authors also manually…

medicine.medical_specialtyApolipoprotein BHypercholesterolemia10265 Clinic for Endocrinology and DiabetologyMEDLINE610 Medicine & health2700 General MedicinePharmacotherapyInternal medicineDiabetes mellitusmedicineHumansLDL-cholesterolRosuvastatinClinical significanceRosuvastatin CalciumAgedClinical Trials as TopicSulfonamidesbiologybusiness.industrynutritional and metabolic diseasesCholesterol LDLGeneral Medicinemedicine.diseaseFluorobenzenesPrimary PreventionClinical trialPyrimidinesTreatment OutcomeEndocrinologyCardiovascular Diseasesrosuvastatin LDL-cholesterol type-2 diabetesHMG-CoA reductasebiology.proteinlipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitorsbusinessmedicine.drug
researchProduct

Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk

2015

Clinical guidelines should be based on the best available evidence and are of great importance for patient care and disease prevention. In this respect, the 2013 American College of Cardiology/American Heart Association report is highly appreciated and well-recognized. The report included critical questions concerning hypercholesterolaemia, but its translation into a clinical guideline initiated intense debate worldwide because of the recommendation to switch from a treat-to-target approach for low-density-lipoprotein-cholesterol to a statin dose-based strategy.

medicine.medical_specialtyConsensusStatinEpidemiologymedicine.drug_classHypercholesterolemia610 Medicine & healthComorbidity030204 cardiovascular system & hematologyRisk Assessment2705 Cardiology and Cardiovascular MedicinePatient care03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk Factors540 ChemistrymedicineHumans030212 general & internal medicineIntensive care medicine10038 Institute of Clinical Chemistrybusiness.industryCholesterolTreat to targetCholesterol LDLGuidelineStatin treatmentTreatment OutcomechemistryCardiovascular DiseasesPractice Guidelines as TopicPhysical therapyLDL Cholesterol Lipoproteinslipids (amino acids peptides and proteins)Disease preventionHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessBiomarkers2713 EpidemiologyEuropean Journal of Preventive Cardiology
researchProduct